All lobbying filings

BELL & LINDSAY, INC.

Lobbying for METABOLIC SYNDROME INSULIN INFUSION HOLDINGS LLC · treatment of metabolic disorders, including diabetes.

Filing Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$15,000.00

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Lobbyists on this filing 1

MARK F LINDSAY

Previously held: U.S House Staff

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Accounting

education around MSII's value proposition to treat metabolic health disorders.

Health Issues

education around MSII's value proposition to treat metabolic health disorders.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.